CTCX: Carmell Corporation Stock

by  •  • Comments Off on CTCX: Carmell Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 55.22
Enterprise Value ($M) 53.59
Book Value ($M) 24.75
Book Value / Share 0.92
Price / Book 2.23
NCAV ($M) 23.70
NCAV / Share 0.88
Price / NCAV 2.33

Profitability (mra)
Return on Invested Capital (ROIC) -0.57
Return on Assets (ROA) -7.06
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.63
Current Ratio 1.63

Balance Sheet (mrq) ($M)
Current Assets 62.90
Assets 63.95
Liabilities 39.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.22
Net Income -15.45
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.35
Cash from Investing -0.03
Cash from Financing 11.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-18 13G/A SANDSTONE Asset Management
02-14 13G/A Sculptor Capital LP 0.00
02-14 13G Meteora Capital, LLC 7.55
02-14 13G/A Balyasny Asset Management Llc 0.00
02-14 13G/A Antara Capital LP 1.60
02-14 13G/A P Schoenfeld Asset Management Lp 0.50
02-07 13G/A Linden Capital L.P. 1.60
02-06 13G Newlin Investment Co 1, LLC
02-05 13G/A Integrated Core Strategies (us) Llc 1.00
11-21 13G Shukla Rajiv

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT
2023-05-16 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ T
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPOR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 1,687 6,620 25.48
2024-05-02 1,165 7 16,642.86
2024-05-01 1,291 733 176.13
2024-04-30 1,420 403 352.36
2024-04-29 4,721 2,380 198.36

(click for more detail)

Similar Companies
CLPT – ClearPoint Neuro, Inc. COCH – Envoy Medical, Inc.
CODX – Co-Diagnostics, Inc. CTSO – Cytosorbents Corporation
DCTH – Delcath Systems, Inc.


Financial data and stock pages provided by
Fintel.io